Mari Suominen

6PUBLICATIONS
11CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 08, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models.

Urs B Hagemann, Christoph A Schatz, Mari I Suominen

|Aug 26, 2023
Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model.

Mari I Suominen, Matias Knuuttila, Birgitta Sjöholm

|Jul 14, 2023
Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis Model.

Jenny Karlsson, Urs B Hagemann, Véronique Cruciani

|Feb 11, 2023
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model.

Mari I Suominen, Matias Knuuttila, Christoph A Schatz

|Jun 02, 2021
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model.

Mari I Suominen, Jenni Mäki-Jouppila, Anna Huhtinen

|Aug 14, 2019
The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis.

Mari I Suominen, Timothy Wilson, Sanna-Maria Käkönen

Pageof 1

Frequent Collaborators

3 joint publications

Dominik Mumberg

3 joint publications

Sanna-Maria Käkönen

2 joint publications

Bernard Haendler

2 joint publications

Matias Knuuttila